Anjali Vaidya, MD, Director of the Advanced Pulmonary Hypertension, Right Heart Failure & Chronic Thromboembolic Pulmonary Hypertension Program at Temple University Hospital, recently participated in a Q&A video series with Healio focusing on pulmonary arterial hypertension (PAH). The six-part interview addressed early recognition and diagnosis of PAH, advancements in targeted treatments, and the use of technology in managing the disease.
During the discussion, Dr. Vaidya highlighted the virtual echocardiography screening tool (VEST), which integrates with electronic medical record systems to generate accurate risk scores for PAH without requiring manual calculations. According to Dr. Vaidya, this approach is unique within pulmonary vascular medicine and was developed by her team at Temple University’s Lewis Katz School of Medicine.
The new tool aims to improve efficiency and accuracy in diagnosing PAH, potentially benefiting both patients and healthcare providers.
